0.7821
price down icon4.12%   -0.0336
after-market Dopo l'orario di chiusura: 2.66 1.8779 +240.11%
loading

Gt Biopharma Inc Azioni (GTBP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Selling, General, and Administrative
38.06%
1.15
0.833 2.297 2.122 2.314
Operating Income/Loss
21.69%
-1.513
-1.932 -3.604 -3.906 -3.091
Nonoperating Income/Loss
93.08%
0.08
1.156 0.193 0.196 0.825
Income/Loss From Continuing Operations Before Tax
79.12%
-1.433
-0.80 -3.411 -3.71 -2.266
Income/Loss From Continuing Operations After Tax
79.12%
-1.433
-0.80 -3.411 -3.71 -2.266
Net Income/Loss
79.12%
-1.433
-0.80 -3.411 -3.71 -2.266
Preferred Stock Dividends And Other Adjustments
0.085
- - - -
Attributable To Noncontrolling Interest
100.00%
-
-0.024 - - -
Basic Average Shares
18.19%
2.7718
2.3451 2.2343 1.712 1.3806
Diluted Average Shares
18.19%
2.7718
2.3451 2.2343 1.712 1.3806
Basic Earnings Per Share
66.67%
-0.55
-0.33 -1.53 -2.17 -1.64
Diluted Earnings Per Share
66.67%
-0.55
-0.33 -1.53 -2.17 -1.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
0.085
- - - -
$36.24
price up icon 1.43%
$86.53
price up icon 0.62%
$28.28
price up icon 0.86%
$96.22
price down icon 0.09%
$144.76
price down icon 0.75%
biotechnology ONC
$334.40
price down icon 2.48%
Capitalizzazione:     |  Volume (24 ore):